"...Shares in Pfizer rose 7 per cent and chief executive Albert Bourla sold US$5.6 million of stock at a whisker from the company’s all-time high.
This drew some negative attention. But Pfizer rolled out a tried-and-tested response. “The sale of these shares is part of Bourla’s personal financial planning and a pre-established (10b5-1) plan, which allows, under SEC rules, major shareholders and insiders of exchange-listed corporations to trade a pre-determined number of shares at a pre-determined time,” Pfizer said."
No comments:
Post a Comment